Gamma-glutamyl transferase (GGT) as an independent predictive factor of sustained virologic response in patients with hepatitis C treated with interferon-alpha and ribavirin

Journal of Clinical Gastroenterology

Volumn 39, Issue 8, 2005, Pages 728-730

  Villela Nogueira, Cristiane Alves ^a,b   Perez, Renata Mello ^a   De Segadas Soares, Jorge André ^a   Moraes Coelho, Henrique Sérgio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Gamma glutamyl transferase; Hepatitis C; Interferon; Ribavirin; Sustained virologic response

Indexed keywords

ALPHA INTERFERON; GAMMA GLUTAMYLTRANSFERASE; RIBAVIRIN;

ADULT; AGE; ARTICLE; BODY MASS; DRUG RESPONSE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 23844498434     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000174025.19214.32     Document Type: Article

References (15)

1. Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet. 2003;362:2095-2100.
2. Martinot-Peignoux M, Boyer N, Pouteau M, et al. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol. 1998;29:214-223.
3. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol. 1994;21:1-3.
4. Serfaty L, Giral P, Loria A, et al. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol. 1994;21:12-17.
5. Piperno A, Sampietro M, Dálba R, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 1996;16:248-254.
6. Mazzella G, Salzetta A, Casanova S, et al. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci. 1994;39:866-870.
7. Mihm S, Monazahian M, Grethe S, et al. Ratio of serum d-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-a in chronic HCV infection. J Med Virol. 1999;58:227-234.
8. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001;357:1069-1075.
9. Giannini E, Botta F, Fasoli A. et al. Increased levels of δ-GT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels and HGV infection on this histological damage. Dig Dis Sci. 2001;3:524-529.
10. Silva IS, Ferraz ML, Perez RM, et al. Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2004;19:314-318.
11. Ohnishi K, Matsuo S, Matsutani K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol. 1996;91:1374-1379.
12. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
13. Tsubota A, Chayama K, Ikeda K, et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology. 1994;19: 1088-1094.
14. Pawlotsky JM, Roudot-Thoraval F, Bastie A, et al. Factors affecting responses to interferon-a in chronic hepatitis C. J Infect Dis. 1996;174:1-7.
15. Berg T, Sarrazin C, Herrmann E, et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology. 2003;37:600-609.